OpenURL Connection Search

Select item for more details and to access through your institution.

Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired Immunity: A Comparison of Three COVID-19 Vaccines.
Published in:
Vaccines, 2022, v. 10, n. 12, p. 2152, doi. 10.3390/vaccines10122152
By:
- Samanovic, Marie I.;
- Oom, Aaron L.;
- Cornelius, Amber R.;
- Gray-Gaillard, Sophie L.;
- Karmacharya, Trishala;
- Tuen, Michael;
- Wilson, Jimmy P.;
- Tasissa, Meron F.;
- Goins, Shelby;
- Herati, Ramin Sedaghat;
- Mulligan, Mark J.
Publication type:
Article
Neutralization of SARS-CoV-2 Variants by mRNA and Adenoviral Vector Vaccine-Elicited Antibodies.
Published in:
Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.797589
By:
- Tada, Takuya;
- Zhou, Hao;
- Samanovic, Marie I.;
- Dcosta, Belinda M.;
- Cornelius, Amber;
- Herati, Ramin S.;
- Mulligan, Mark J.;
- Landau, Nathaniel R.
Publication type:
Article
SARS-CoV-2 inflammation durably imprints memory CD4 T cells.
Published in:
Science Immunology, 2024, v. 9, n. 96, p. 1, doi. 10.1126/sciimmunol.adj8526
By:
- Gray-Gaillard, Sophie L.;
- Solis, Sabrina M.;
- Chen, Han M.;
- Monteiro, Clarice;
- Ciabattoni, Grace;
- Samanovic, Marie I.;
- Cornelius, Amber R.;
- Williams, Tijaana;
- Geesey, Emilie;
- Rodriguez, Miguel;
- Ortigoza, Mila Brum;
- Ivanova, Ellie N.;
- Koralov, Sergei B.;
- Mulligan, Mark J.;
- Herati, Ramin Sedaghat
Publication type:
Article
Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination.
Published in:
Annals of Clinical & Translational Neurology, 2024, v. 11, n. 7, p. 1750, doi. 10.1002/acn3.52081
By:
- Kister, Ilya;
- Curtin, Ryan;
- Piquet, Amanda L.;
- Borko, Tyler;
- Pei, Jinglan;
- Banbury, Barbara L;
- Bacon, Tamar E.;
- Kim, Angie;
- Tuen, Michael;
- Velmurugu, Yogambigai;
- Nyovanie, Samantha;
- Selva, Sean;
- Samanovic, Marie I.;
- Mulligan, Mark J.;
- Patskovsky, Yury;
- Priest, Jessica;
- Cabatingan, Mark;
- Winger, Ryan C.;
- Krogsgaard, Michelle;
- Silverman, Gregg J.
Publication type:
Article
Hybrid and vaccine‐induced immunity against SAR‐CoV‐2 in MS patients on different disease‐modifying therapies.
Published in:
Annals of Clinical & Translational Neurology, 2022, v. 9, n. 10, p. 1643, doi. 10.1002/acn3.51664
By:
- Kister, Ilya;
- Curtin, Ryan;
- Pei, Jinglan;
- Perdomo, Katherine;
- Bacon, Tamar E.;
- Voloshyna, Iryna;
- Kim, Joseph;
- Tardio, Ethan;
- Velmurugu, Yogambigai;
- Nyovanie, Samantha;
- Valeria Calderon, Andrea;
- Dibba, Fatoumatta;
- Stanzin, Igda;
- Samanovic, Marie I.;
- Raut, Pranil;
- Raposo, Catarina;
- Priest, Jessica;
- Cabatingan, Mark;
- Winger, Ryan C.;
- Mulligan, Mark J.
Publication type:
Article
Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study.
Published in:
Annals of Neurology, 2022, v. 91, n. 6, p. 782, doi. 10.1002/ana.26346
By:
- Kister, Ilya;
- Patskovsky, Yury;
- Curtin, Ryan;
- Pei, Jinglan;
- Perdomo, Katherine;
- Rimler, Zoe;
- Voloshyna, Iryna;
- Samanovic, Marie I.;
- Cornelius, Amber R.;
- Velmurugu, Yogambigai;
- Nyovanie, Samantha;
- Kim, Joseph J.;
- Tardio, Ethan;
- Bacon, Tamar E.;
- Zhovtis Ryerson, Lana;
- Raut, Pranil;
- Pedotti, Rosetta;
- Hawker, Kathleen;
- Raposo, Catarina;
- Priest, Jessica
Publication type:
Article
Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities.
Published in:
Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84913-3
By:
- Noval, Maria G.;
- Kaczmarek, Maria E.;
- Koide, Akiko;
- Rodriguez-Rodriguez, Bruno A.;
- Louie, Ping;
- Tada, Takuya;
- Hattori, Takamitsu;
- Panchenko, Tatyana;
- Romero, Larizbeth A.;
- Teng, Kai Wen;
- Bazley, Andrew;
- de Vries, Maren;
- Samanovic, Marie I.;
- Weiser, Jeffrey N.;
- Aifantis, Ioannis;
- Cangiarella, Joan;
- Mulligan, Mark J.;
- Desvignes, Ludovic;
- Dittmann, Meike;
- Landau, Nathaniel R.
Publication type:
Article
Immunogenicity after heterologous third dose COVID‐19 vaccination in a heart transplant recipient.
Published in:
Clinical Transplantation, 2022, v. 36, n. 4, p. 1, doi. 10.1111/ctr.14605
By:
- Mehta, Sapna A.;
- Reyentovich, Alex;
- Montgomery, Robert A.;
- Segev, Dorry L.;
- Gebel, Howard M.;
- Bray, Robert A.;
- Samanovic, Marie I.;
- Cornelius, Amber R.;
- Mulligan, Mark J.;
- Herati, Ramin S.
Publication type:
Article
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals.
Published in:
Science Translational Medicine, 2022, v. 14, n. 631, p. 1, doi. 10.1126/scitranslmed.abi8961
By:
- Samanovic, Marie I.;
- Cornelius, Amber R.;
- Gray-Gaillard, Sophie L.;
- Allen, Joseph Richard;
- Karmacharya, Trishala;
- Wilson, Jimmy P.;
- Hyman, Sara Wesley;
- Tuen, Michael;
- Koralov, Sergei B.;
- Mulligan, Mark J.;
- Herati, Ramin Sedaghat
Publication type:
Article
Generation of quality-controlled SARS-CoV-2 variant stocks.
Published in:
Nature Protocols, 2023, v. 18, n. 12, p. 3821, doi. 10.1038/s41596-023-00897-6
By:
- de Vries, Maren;
- Ciabattoni, Grace O.;
- Rodriguez-Rodriguez, Bruno A.;
- Crosse, Keaton M.;
- Papandrea, Dominick;
- Samanovic, Marie I.;
- Dimartino, Dacia;
- Marier, Christian;
- Mulligan, Mark J.;
- Heguy, Adriana;
- Desvignes, Ludovic;
- Duerr, Ralf;
- Dittmann, Meike
Publication type:
Article

Found: 10